Metropolis Healthcare Limited

NSEI:METROPOLIS 株式レポート

時価総額:₹111.9b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Metropolis Healthcare マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Surendran Chemmenkotil

最高経営責任者

₹52.3m

報酬総額

CEO給与比率23.9%
CEO在任期間1.7yrs
CEOの所有権n/a
経営陣の平均在職期間1.4yrs
取締役会の平均在任期間5.2yrs

経営陣の近況

Recent updates

Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Aug 14
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

May 24
Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Mar 28
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Jan 13
Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Dec 23
Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Sep 08
Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Jun 20
Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Mar 14
Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Feb 13
Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Sep 25
Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Sep 10
Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Jun 07
Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

May 16
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Mar 17
Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Jan 29
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Dec 14
Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Oct 12
Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Aug 27
Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

Jul 06
Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease

May 28
I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease

Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns

Mar 29
Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns

Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?

Mar 11
Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?

CEO報酬分析

Metropolis Healthcare の収益と比較して、Surendran Chemmenkotil の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

₹1b

Mar 31 2024n/an/a

₹1b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹52m₹13m

₹1b

報酬と市場: Surendranの 総報酬 ($USD 625.31K ) は、 Indian市場 ($USD 489.17K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Surendranの報酬と会社の業績を比較するにはデータが不十分です。


CEO(最高経営責任者

Surendran Chemmenkotil

1.7yrs

在職期間

₹52,318,552

報酬

Mr. Surendran Chemmenkotil is Chief Executive Officer of Metropolis Healthcare Limited from January 2, 2023. He is a seasoned leader with rich and diverse experience across consumer facing companies such a...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Ameera Shah
Executive Chairperson16.3yrs₹47.88m0.35%
₹ 397.0m
Sushil Shah
Founder & Chairman Emeritusno data₹18.00m18.47%
₹ 20.7b
Surendran Chemmenkotil
Chief Executive Officer1.7yrs₹52.32mデータなし
Rakesh Agarwal
Chief Financial Officer4.8yrs₹13.83mデータなし
Kannan Alangadan
Chief Operating Officerno dataデータなしデータなし
Kirti Chadha
Chief Scientific & Innovation Officerno dataデータなしデータなし
Pinakin Shah
Chief Information Officerno dataデータなしデータなし
Kamlesh Kulkarni
Head of Legal & Secretarial and Compliance Officerless than a yearデータなしデータなし
Jeyasingh Balakrishnan
Head of Public Relations & Corporate Communications3yrsデータなしデータなし
Mohan Menon
Chief Marketing Officer1.1yrsデータなしデータなし
Ishita Medhekar
Chief People Officer4.7yrsデータなしデータなし
Nilesh Shah
President of Internal Assurance & Advisor to CEOno dataデータなしデータなし

1.4yrs

平均在職期間

経験豊富な経営陣: METROPOLISの経営陣は 経験豊富 とはみなされません ( 1.4年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Ameera Shah
Executive Chairperson16.3yrs₹47.88m0.35%
₹ 397.0m
Sushil Shah
Founder & Chairman Emeritus19.1yrs₹18.00m18.47%
₹ 20.7b
Anita Ramachandran
Non-Executive Independent Director4.3yrs₹2.18mデータなし
Sanjay Bhatnagar
Non-Executive Independent Director6yrs₹1.73mデータなし
Vivek Gambhir
Non-Executive Independent Director6yrs₹1.85m0.00028%
₹ 313.2k
Ranganathan Subramanian
Independent Directorless than a year₹500.00kデータなし
Hemant Sachdev
Non-Executive Independent Director3.3yrsデータなしデータなし
Aparna Rajadhyaksha
Non-Executive Directorless than a yearデータなしデータなし

5.2yrs

平均在職期間

58.5yo

平均年齢

経験豊富なボード: METROPOLISの 取締役会経験豊富 であると考えられます ( 4.9年の平均在任期間)。